BackREYON Pharmaceutical , Ltd. Overview

REYON Pharmaceutical , Ltd. Receivables

Track REYON Pharmaceutical , Ltd.'s receivables ($35B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$34.68B
↓ 3.81% YoYΔ $-1.37B vs prior year quarter

Peer trimmed avg / median

Loading

REYON Pharmaceutical , Ltd. Receivables History

Loading

REYON Pharmaceutical , Ltd. vs. peers: Receivables Comparison

Loading

REYON Pharmaceutical , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

REYON Pharmaceutical , Ltd. (102460.KS) FAQ

REYON Pharmaceutical , Ltd. (102460.KS) currently reports a receivables of $35B as of June 2026. That compares with $36B in the prior-year period — down 3.8% year over year. Use the charts on this page to explore REYON Pharmaceutical , Ltd.'s receivables history and peer comparisons.

REYON Pharmaceutical , Ltd.'s receivables decreased from $36B to $35B — a 3.8% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

REYON Pharmaceutical , Ltd. reported $35B in receivables as of June 2026. That compares with $36B in the prior-year period — down 3.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $35B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for REYON Pharmaceutical , Ltd., and consider following 102460.KS for alerts when major investors trade the stock.